Akero Therapeutics Inc buy UBS Group AG
Start price
28.08.23
/
50%
€46.20
Target price
28.08.24
€76.75
Performance (%)
-57.92%
Price
22:26
€19.44
Summary
This prediction is currently active. Massive losses of -57.92% have been the result for the BUY prediction by UBS_Group_AG. This prediction currently runs until 28.08.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akero Therapeutics Inc | 0.307% | 0.307% |
| iShares Core DAX® | 3.178% | 0.980% |
| iShares Nasdaq 100 | 2.972% | 0.925% |
| iShares Nikkei 225® | 0.545% | -4.556% |
| iShares S&P 500 | 2.367% | 0.833% |
Comments by UBS_Group_AG for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $83.00 price target on the stock.
Ratings data for AKRO provided by MarketBeat
Stopped prediction by UBS_Group_AG for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
05.03.24
05.03.24
€38.62
05.03.25
05.03.25
-26.92%
22:26
22:26
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€14.00
12.10.23
12.10.23
€37.01
12.10.24
12.10.24
38.86%
22:26
22:26